Literature DB >> 28329051

Caloric Restriction Mimetics Slow Aging of Neuromuscular Synapses and Muscle Fibers.

Jessica Stockinger1,2, Nicholas Maxwell1, Dillon Shapiro1, Rafael deCabo3, Gregorio Valdez1,4.   

Abstract

Resveratrol and metformin have been shown to mimic some aspects of caloric restriction and exercise. However, it remains unknown if these molecules also slow age-related synaptic degeneration, as previously shown for caloric restriction and exercise. In this study, we examined the structural integrity of neuromuscular junctions (NMJs) in 2-year-old mice treated with resveratrol and metformin starting at 1 year of age. We found that resveratrol significantly slows aging of NMJs in the extensor digitorum longus muscle of 2-year-old mice. Resveratrol also preserved the morphology of muscle fibers in old mice. Although metformin slowed the rate of muscle fiber aging, it did not significantly affect aging of NMJs. Based on these findings, we sought to determine if resveratrol directly affects NMJs. For this, we examined postsynaptic sites, the NMJ region located on the muscle peripheral membrane, on cultured myotubes derived from C2C12 cells. We discovered that resveratrol increases the number of postsynaptic sites on myotubes exhibiting a youthful architecture, suggesting that resveratrol directly affects the NMJ. Altogether, we provide compelling evidence indicating that resveratrol slows aging of NMJs and muscle fibers.
© The Author(s) 2017. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Metabolism; Metformin; Myotube; NMJ; Resveratrol

Mesh:

Substances:

Year:  2017        PMID: 28329051      PMCID: PMC5861854          DOI: 10.1093/gerona/glx023

Source DB:  PubMed          Journal:  J Gerontol A Biol Sci Med Sci        ISSN: 1079-5006            Impact factor:   6.053


  45 in total

Review 1.  Development of the vertebrate neuromuscular junction.

Authors:  J R Sanes; J W Lichtman
Journal:  Annu Rev Neurosci       Date:  1999       Impact factor: 12.449

2.  Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span.

Authors:  Kevin J Pearson; Joseph A Baur; Kaitlyn N Lewis; Leonid Peshkin; Nathan L Price; Nazar Labinskyy; William R Swindell; Davida Kamara; Robin K Minor; Evelyn Perez; Hamish A Jamieson; Yongqing Zhang; Stephen R Dunn; Kumar Sharma; Nancy Pleshko; Laura A Woollett; Anna Csiszar; Yuji Ikeno; David Le Couteur; Peter J Elliott; Kevin G Becker; Placido Navas; Donald K Ingram; Norman S Wolf; Zoltan Ungvari; David A Sinclair; Rafael de Cabo
Journal:  Cell Metab       Date:  2008-07-03       Impact factor: 27.287

Review 3.  Aging, synaptic dysfunction, and insulin-like growth factor (IGF)-1.

Authors:  Ferenc Deak; William E Sonntag
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-04-12       Impact factor: 6.053

4.  Short-term caloric restriction, resveratrol, or combined treatment regimens initiated in late-life alter mitochondrial protein expression profiles in a fiber-type specific manner in aged animals.

Authors:  Anna-Maria Joseph; Angelina G Malamo; Jason Silvestre; Nick Wawrzyniak; Sean Carey-Love; Linda M-D Nguyen; Debapriya Dutta; Jinze Xu; Christiaan Leeuwenburgh; Peter J Adhihetty
Journal:  Exp Gerontol       Date:  2013-06-07       Impact factor: 4.032

5.  Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan.

Authors:  Konrad T Howitz; Kevin J Bitterman; Haim Y Cohen; Dudley W Lamming; Siva Lavu; Jason G Wood; Robert E Zipkin; Phuong Chung; Anne Kisielewski; Li-Li Zhang; Brandy Scherer; David A Sinclair
Journal:  Nature       Date:  2003-08-24       Impact factor: 49.962

6.  Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5.

Authors:  Paul W Caton; Nanda K Nayuni; Julius Kieswich; Noorafza Q Khan; Muhammed M Yaqoob; Roger Corder
Journal:  J Endocrinol       Date:  2010-01-21       Impact factor: 4.286

7.  At concentrations that inhibit mTOR, resveratrol suppresses cellular senescence.

Authors:  Zoya N Demidenko; Mikhail V Blagosklonny
Journal:  Cell Cycle       Date:  2009-06-21       Impact factor: 4.534

8.  AMPK agonist AICAR improves cognition and motor coordination in young and aged mice.

Authors:  Tali Kobilo; Davide Guerrieri; Yongqing Zhang; Sarah C Collica; Kevin G Becker; Henriette van Praag
Journal:  Learn Mem       Date:  2014-01-17       Impact factor: 2.460

9.  Neuroprotective effects of resveratrol and epigallocatechin gallate polyphenols are mediated by the activation of protein kinase C gamma.

Authors:  Caroline Menard; Stéphane Bastianetto; Rémi Quirion
Journal:  Front Cell Neurosci       Date:  2013-12-26       Impact factor: 5.505

10.  The mTOR Inhibitor Rapamycin Mitigates Perforant Pathway Neurodegeneration and Synapse Loss in a Mouse Model of Early-Stage Alzheimer-Type Tauopathy.

Authors:  Robert Siman; Ryan Cocca; Yina Dong
Journal:  PLoS One       Date:  2015-11-05       Impact factor: 3.240

View more
  14 in total

Review 1.  Effects of disease-afflicted and aging neurons on the musculoskeletal system.

Authors:  Gregorio Valdez
Journal:  Bone       Date:  2019-01-26       Impact factor: 4.398

2.  Caloric Restriction Research: New Perspectives on the Biology of Aging.

Authors:  Rozalyn M Anderson; David G Le Couteur; Rafael de Cabo
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-12-12       Impact factor: 6.053

3.  Resveratrol-Inspired Bridged Bicyclic Compounds: A New Compound Class for the Protection of Synaptic Function from Acute Oxidative Stress.

Authors:  Wesley L Bollinger; Elijah J St Germain; Samantha L Maki; Nadia K Sial; Salvatore D Lepore; Ken Dawson-Scully
Journal:  ACS Chem Neurosci       Date:  2018-11-28       Impact factor: 4.418

4.  Secondary denervation is a chronic pathophysiologic sequela of volumetric muscle loss.

Authors:  Jacob R Sorensen; Daniel B Hoffman; Benjamin T Corona; Sarah M Greising
Journal:  J Appl Physiol (1985)       Date:  2021-04-08

Review 5.  Exploring the Comparative Efficacy of Metformin and Resveratrol in the Management of Diabetes-associated Complications: A Systematic Review of Preclinical Studies.

Authors:  Phiwayinkosi V Dludla; Sonia Silvestri; Patrick Orlando; Kwazi B Gabuza; Sithandiwe E Mazibuko-Mbeje; Tawanda M Nyambuya; Vuyolwethu Mxinwa; Kabelo Mokgalaboni; Rabia Johnson; Christo J F Muller; Luca Tiano; Johan Louw; Bongani B Nkambule
Journal:  Nutrients       Date:  2020-03-11       Impact factor: 5.717

6.  Increased 1,25(OH)2-Vitamin D Concentrations after Energy Restriction Are Associated with Changes in Skeletal Muscle Phenotype.

Authors:  Angela Vidal; Rafael Rios; Carmen Pineda; Ignacio Lopez; Ana I Raya; Escolastico Aguilera-Tejero; Jose-Luis L Rivero
Journal:  Nutrients       Date:  2021-02-12       Impact factor: 5.717

Review 7.  Age-Related Alterations at Neuromuscular Junction: Role of Oxidative Stress and Epigenetic Modifications.

Authors:  Gabriella Dobrowolny; Alessandra Barbiera; Gigliola Sica; Bianca Maria Scicchitano
Journal:  Cells       Date:  2021-05-24       Impact factor: 6.600

8.  Searching for a mitochondrial root to the decline in muscle function with ageing.

Authors:  Marta Gonzalez-Freire; Fatemeh Adelnia; Ruin Moaddel; Luigi Ferrucci
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-05-18       Impact factor: 12.910

9.  Concurrent treatment with ursolic acid and low-intensity treadmill exercise improves muscle atrophy and related outcomes in rats.

Authors:  Jae Cheol Kim; Yun Seok Kang; Eun Bi Noh; Baek Woon Seo; Dae Yun Seo; Gi Duck Park; Sang Hyun Kim
Journal:  Korean J Physiol Pharmacol       Date:  2018-06-25       Impact factor: 2.016

10.  SIRT1 deacetylase in aging-induced neuromuscular degeneration and amyotrophic lateral sclerosis.

Authors:  Adrianna Z Herskovits; Tegan A Hunter; Nicholas Maxwell; Katherine Pereira; Charles A Whittaker; Gregorio Valdez; Leonard P Guarente
Journal:  Aging Cell       Date:  2018-10-08       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.